1
|
de Kort W, van Kraaij M, van den Hurk K. Donor base management: painting Gabriel's horn - Comment on Beckman et al., 2016. Transfus Med 2017; 27:460-461. [PMID: 29282808 DOI: 10.1111/tme.12499] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2016] [Accepted: 12/04/2017] [Indexed: 11/28/2022]
Affiliation(s)
- W de Kort
- Donor Studies Department, Sanquin Blood Supply, Amsterdam, the Netherlands
| | - M van Kraaij
- Donor Studies Department, Sanquin Blood Supply, Amsterdam, the Netherlands
| | - K van den Hurk
- Donor Studies Department, Sanquin Blood Supply, Amsterdam, the Netherlands
| |
Collapse
|
2
|
Manzini PM, Dall'Omo AM, D'Antico S, Valfrè A, Pendry K, Wikman A, Fischer D, Borg-Aquilina D, Laspina S, van Pampus ECM, van Kraaij M, Bruun MT, Georgsen J, Grant-Casey J, Babra PS, Murphy MF, Folléa G, Aranko K. Patient blood management knowledge and practice among clinicians from seven European university hospitals: a multicentre survey. Vox Sang 2017; 113:60-71. [DOI: 10.1111/vox.12599] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2017] [Revised: 09/12/2017] [Accepted: 09/12/2017] [Indexed: 01/28/2023]
Affiliation(s)
- P. M. Manzini
- Banca del Sangue e del Plasma; Città della Salute e della Scienza di Torino; Torino Italy
| | - A. M. Dall'Omo
- Banca del Sangue e del Plasma; Città della Salute e della Scienza di Torino; Torino Italy
| | - S. D'Antico
- Banca del Sangue e del Plasma; Città della Salute e della Scienza di Torino; Torino Italy
| | - A. Valfrè
- Banca del Sangue e del Plasma; Città della Salute e della Scienza di Torino; Torino Italy
| | - K. Pendry
- Department of Transfusion; Central Manchester University Hospitals NHS Foundation Trust; Manchester UK
| | - A. Wikman
- Department of Clinical Immunology and Transfusion Medicine; Karolinska University Hospital; Stockholm Sweden
| | - D. Fischer
- Department of Anesthesiology, Intensive Care Medicine and Pain Therapy; University Hospital Frankfurt; Frankfurt Germany
| | - D. Borg-Aquilina
- Hospital Blood Bank; Mater Dei University Hospital; Msida Malta
| | - S. Laspina
- Hospital Blood Bank; Mater Dei University Hospital; Msida Malta
| | - E. C. M. van Pampus
- Laboratory of Medical Immunology; Radboud University Medical Center; Nijmegen The Netherlands
| | - M. van Kraaij
- Laboratory of Medical Immunology; Radboud University Medical Center; Nijmegen The Netherlands
- Department of Transfusion Medicine and Donor Affairs; Sanquin Blood bank; Amsterdam The Netherlands
| | - M. T. Bruun
- Department of Clinical Immunology; Odense University Hospital; Odense Denmark
| | - J. Georgsen
- Department of Clinical Immunology; Odense University Hospital; Odense Denmark
| | | | - P. S. Babra
- Oxford Blood Centre; NHS Blood & Transplant; Oxford UK
| | - M. F. Murphy
- Oxford Blood Centre; NHS Blood & Transplant; Oxford UK
| | - G. Folléa
- French Blood Establishment; Saint Denis France
| | - K. Aranko
- European Blood Alliance; Amsterdam The Netherlands
| |
Collapse
|
3
|
Bosboom JJ, Klanderman RB, Peters AL, van de Weerdt EK, Goudswaard EJ, Binnekade JM, Zwaginga JJ, Beckers EAM, Geerts BF, Hollmann MW, Zeerleder SS, van Kraaij M, Vlaar AP. The practice of diagnosing and reporting transfusion-associated circulatory overload: a national survey among physicians and haemovigilance officers. Transfus Med 2017; 28:363-370. [PMID: 29058354 DOI: 10.1111/tme.12480] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2017] [Revised: 08/25/2017] [Accepted: 09/16/2017] [Indexed: 11/27/2022]
Abstract
OBJECTIVES This study aims at identifying factors that disciplines consider when diagnosing and reporting transfusion-associated circulatory overload ('TACO'). BACKGROUND TACO is a clinical diagnosis based mainly on subjective factors. Therefore, TACO could be an underreported complication of blood transfusion. METHODS A survey was conducted among critical care physicians, anaesthesiologists, haematologists, transfusion medicine physicians and haemovigilance officers using case vignettes and a questionnaire. Factors that may affect diagnosing TACO were investigated using conjoint analysis. A positive B-coefficient indicates a positive preference for diagnosing TACO. Participants rated factors influencing reporting TACO on a 0- to 100-point scale. RESULTS One hundred and seven surveys were returned (62%). Vignettes showed preferences in favour of diagnosing TACO with the onset of symptoms within 2 h [β 0·4(-0·1-1·0)], positive fluid balance [β 0·9(0·4-1·5)] and history of renal failure [β 0·6(0·1-1·2)]. Compared with transfusion of a single unit of red blood cells (RBC), respondents showed a preference for diagnosing TACO following a single unit of solvent/detergent (S/D) plasma or pooled platelet concentrate (PPC) [β 0·3(-0·2-0·7) resp. 0·5(-0·1-1·2)]. Multiple transfusion (6 RBC + 4 S/D plasma) was a strong preference for diagnosing TACO compared to 1 RBC and 1 S/D plasma [β 0·3(-0·8-1·3)]. Respondents did not fully take into account new hypertension and tachycardia when reporting TACO [median 70 (IQR 50-80) resp. 60 (IQR 50-80)]. No differences were observed between disciplines involved. CONCLUSION When diagnosing and reporting TACO, physicians and haemovigilance officers do consider known risk factors for TACO. Reporting could be improved by increasing the awareness of haemodynamic variables in future education programmes.
Collapse
Affiliation(s)
- J J Bosboom
- Department of Anaesthesiology, Academic Medical Centre, Amsterdam, the Netherlands
| | - R B Klanderman
- Department of Intensive Care Medicine, Academic Medical Centre, Amsterdam, the Netherlands.,Laboratory of Experimental Intensive Care and Anaesthesiology (L.E.I.C.A.), Academic Medical Centre, Amsterdam, the Netherlands
| | - A L Peters
- Department of Intensive Care Medicine, Academic Medical Centre, Amsterdam, the Netherlands.,Laboratory of Experimental Intensive Care and Anaesthesiology (L.E.I.C.A.), Academic Medical Centre, Amsterdam, the Netherlands
| | - E K van de Weerdt
- Department of Intensive Care Medicine, Academic Medical Centre, Amsterdam, the Netherlands
| | - E J Goudswaard
- Department of Intensive Care Medicine, Academic Medical Centre, Amsterdam, the Netherlands
| | - J M Binnekade
- Department of Intensive Care Medicine, Academic Medical Centre, Amsterdam, the Netherlands
| | - J J Zwaginga
- Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, Leiden, the Netherlands.,Centre for Clinical Transfusion Research, Sanquin Blood Supply, Sanquin Research, Leiden, the Netherlands
| | - E A M Beckers
- Department of Internal Medicine - Haematology, Maastricht University Medical Centre, Maastricht, the Netherlands
| | - B F Geerts
- Department of Anaesthesiology, Academic Medical Centre, Amsterdam, the Netherlands
| | - M W Hollmann
- Department of Anaesthesiology, Academic Medical Centre, Amsterdam, the Netherlands.,Laboratory of Experimental Intensive Care and Anaesthesiology (L.E.I.C.A.), Academic Medical Centre, Amsterdam, the Netherlands
| | - S S Zeerleder
- Department of Internal Medicine - Haematology, Academic Medical Centre, Amsterdam, the Netherlands
| | - M van Kraaij
- Centre for Clinical Transfusion Research, Sanquin Blood Supply, Sanquin Research, Leiden, the Netherlands
| | - A P Vlaar
- Department of Intensive Care Medicine, Academic Medical Centre, Amsterdam, the Netherlands.,Laboratory of Experimental Intensive Care and Anaesthesiology (L.E.I.C.A.), Academic Medical Centre, Amsterdam, the Netherlands
| |
Collapse
|
4
|
Bruun MT, Pendry K, Georgsen J, Manzini P, Lorenzi M, Wikman A, Borg-Aquilina D, van Pampus E, van Kraaij M, Fischer D, Meybohm P, Zacharowski K, Geisen C, Seifried E, Liumbruno GM, Folléa G, Grant-Casey J, Babra P, Murphy MF. Patient Blood Management in Europe: surveys on top indications for red blood cell use and Patient Blood Management organization and activities in seven European university hospitals. Vox Sang 2016; 111:391-398. [DOI: 10.1111/vox.12435] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2016] [Revised: 06/07/2016] [Accepted: 06/28/2016] [Indexed: 01/28/2023]
Affiliation(s)
- M. T. Bruun
- Department of Clinical Immunology; Odense University Hospital; Odense Denmark
| | - K. Pendry
- Department of Transfusion; Central Manchester University Hospitals NHS Foundation Trust; Manchester UK
- NHS Blood & Transplant; Manchester UK
| | - J. Georgsen
- Department of Clinical Immunology; Odense University Hospital; Odense Denmark
| | - P. Manzini
- Banca del Sangue e del Plasma CPVE; Città della Salute e della Scienza di Torino; Torino Italy
| | - M. Lorenzi
- Banca del Sangue e del Plasma CPVE; Città della Salute e della Scienza di Torino; Torino Italy
| | - A. Wikman
- Department of Clinical Immunology and Transfusion Medicine; Karolinska University Hospital; Stockholm Sweden
| | | | - E. van Pampus
- Laboratory of Medical Immunology; Radboud University Medical Centre; Nijmegen The Netherlands
| | - M. van Kraaij
- Department of Transfusion Medicine; Sanquin Blood Bank; Amsterdam The Netherlands
| | - D. Fischer
- Department of Anaesthesiology; Intensive Care Medicine and Pain Therapy; University Hospital Frankfurt; Frankfurt Germany
| | - P. Meybohm
- Department of Anaesthesiology; Intensive Care Medicine and Pain Therapy; University Hospital Frankfurt; Frankfurt Germany
| | - K. Zacharowski
- Department of Anaesthesiology; Intensive Care Medicine and Pain Therapy; University Hospital Frankfurt; Frankfurt Germany
| | - C. Geisen
- German Red Cross Blood Service Baden-Wuerttemberg-Hessen; Institute of Transfusion Medicine and Immunohaematology; Frankfurt Germany
| | - E. Seifried
- German Red Cross Blood Service Baden-Wuerttemberg-Hessen; Institute of Transfusion Medicine and Immunohaematology; Frankfurt Germany
| | - G. M. Liumbruno
- Italian National Blood Centre; National Institute of Health; Rome Italy
| | - G. Folléa
- European Blood Alliance; Amsterdam The Netherlands
| | | | - P. Babra
- NHS Blood & Transplant; Manchester UK
| | - M. F. Murphy
- NHS Blood & Transplant; Manchester UK
- Oxford University Hospitals NHS Foundation Trust; Oxford UK
- University of Oxford; Oxford UK
| |
Collapse
|
5
|
Geisen C, Kann G, Strecker T, Wolf T, Schüttfort G, van Kraaij M, MacLennan S, Rummler S, Weinigel C, Eickmann M, Fehling SK, Krähling V, Seidl C, Seifried E, Schmidt M, Schäfer R. Pathogen-reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola-specific neutralizing antibodies. Vox Sang 2016; 110:329-35. [PMID: 26766162 DOI: 10.1111/vox.12376] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2015] [Revised: 12/08/2015] [Accepted: 12/09/2015] [Indexed: 01/16/2023]
Abstract
BACKGROUND Ebola virus disease is a public health emergency of international concern, and enormous efforts are being made in the development of vaccines and therapies. Ebola virus convalescent plasma is a promising anti-infective treatment of Ebola virus disease. Therefore, we developed and implemented a pathogen-reduced Ebola virus convalescent plasma concept in accordance with national, European and global regulatory framework. MATERIALS AND METHODS Ebola virus convalescent plasma manufacture and distribution was managed by a collection centre, two medical centres and an expert group from the European Blood Alliance. Ebola virus convalescent plasma was collected twice with an interval of 61 days from a donor recovering from Ebola virus disease in Germany. After pathogen reduction, the plasma was analysed for Ebola virus-specific immunoglobulin G (IgG) antibodies and its Ebola virus neutralizing activity. RESULTS Convalescent plasma could be collected without adverse events. Anti-Ebola virus IgG titres and Ebola-specific neutralizing antibodies in convalescent plasma were only slightly reduced after pathogen reduction treatment with S59 amotosalen/UVA. A patient in Italy with Ebola virus disease was treated with convalescent plasma without apparent adverse effects. DISCUSSION As proof of principle, we describe a concept and practical implementation of pathogen-reduced Ebola virus convalescent plasma manufacture, quality control and its clinical application to an Ebola virus disease patient.
Collapse
Affiliation(s)
- C Geisen
- Institute for Transfusion Medicine and Immunohaematology, German Red Cross Blood Donor Service Baden-Württemberg-Hessen gGmbH, Goethe University Hospital, Frankfurt am Main, Germany
| | - G Kann
- Department of Infectious Diseases, Goethe University Hospital, Frankfurt am Main, Germany
| | - T Strecker
- Institute of Virology, Philipps University Marburg, Marburg, Germany
| | - T Wolf
- Department of Infectious Diseases, Goethe University Hospital, Frankfurt am Main, Germany
| | - G Schüttfort
- Department of Infectious Diseases, Goethe University Hospital, Frankfurt am Main, Germany
| | | | | | - S Rummler
- Institute of Transfusion Medicine, University Hospital Jena, Jena, Germany
| | - C Weinigel
- Institute of Transfusion Medicine, University Hospital Jena, Jena, Germany
| | - M Eickmann
- Institute of Virology, Philipps University Marburg, Marburg, Germany
| | - S K Fehling
- Institute of Virology, Philipps University Marburg, Marburg, Germany
| | - V Krähling
- Institute of Virology, Philipps University Marburg, Marburg, Germany
| | - C Seidl
- Institute for Transfusion Medicine and Immunohaematology, German Red Cross Blood Donor Service Baden-Württemberg-Hessen gGmbH, Goethe University Hospital, Frankfurt am Main, Germany
| | - E Seifried
- Institute for Transfusion Medicine and Immunohaematology, German Red Cross Blood Donor Service Baden-Württemberg-Hessen gGmbH, Goethe University Hospital, Frankfurt am Main, Germany
| | - M Schmidt
- Institute for Transfusion Medicine and Immunohaematology, German Red Cross Blood Donor Service Baden-Württemberg-Hessen gGmbH, Goethe University Hospital, Frankfurt am Main, Germany
| | - R Schäfer
- Institute for Transfusion Medicine and Immunohaematology, German Red Cross Blood Donor Service Baden-Württemberg-Hessen gGmbH, Goethe University Hospital, Frankfurt am Main, Germany
| |
Collapse
|
6
|
Stevens-Kroef MJPL, Schoenmakers EFPM, van Kraaij M, Huys E, Vermeulen S, van der Reijden B, van Kessel AG. Identification of truncated RUNX1 and RUNX1-PRDM16 fusion transcripts in a case of t(1;21)(p36;q22)-positive therapy-related AML. Leukemia 2006; 20:1187-9. [PMID: 16598304 DOI: 10.1038/sj.leu.2404210] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
MESH Headings
- Acute Disease
- Chromosomes, Human, Pair 1
- Chromosomes, Human, Pair 21
- Core Binding Factor Alpha 2 Subunit/genetics
- DNA-Binding Proteins/genetics
- Fatal Outcome
- Female
- Humans
- Leukemia, Myeloid/diagnosis
- Leukemia, Myeloid/genetics
- Leukemia, Myeloid/therapy
- Middle Aged
- Oncogene Proteins, Fusion/genetics
- Reverse Transcriptase Polymerase Chain Reaction
- Transcription Factors/genetics
- Transcription, Genetic
- Translocation, Genetic
Collapse
|
7
|
Huvers F, Slappendel R, Benraad B, van Hellemondt G, van Kraaij M. Treatment of postoperative bleeding after fondaparinux with rFVIIa and tranexamic acid. Neth J Med 2005; 63:184-6. [PMID: 15952489] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
Abstract
Treatment of a haemorrhagic shock after just a single dose of fondaparinux in an orthopaedic patient with reduced renal clearance is presented. Since all routine haemostatic parameters were nearly normal, single doses of rFVIIa (90 microg/kg) and of tranexamic acid (15 mg/kg) were administered to improve thrombin generation and reduce fibrinolysis. This case is the first showing the effectiveness of combining single doses of rFVIIa and tranexamic acid in controlling severe postoperative bleeding after fondaparinux.
Collapse
Affiliation(s)
- F Huvers
- Department of Internal Medicine, Sint Maartenskliniek, Nijmegen, The Netherlands.
| | | | | | | | | |
Collapse
|